Covered recipient · General Payments record
AMIRFARBOD YAZDANYAR
Allopathic & Osteopathic Physicians Ophthalmology Retina Specialist
General Payments · PY2018–2024
$5,638.74
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,382.00 | 1 |
| Travel and Lodging | $755.44 | 1 |
| Food and Beverage | $654.05 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $2,649.45 | 3 |
| Ocular Therapeutix, Inc. | $1,052.87 | 5 |
| Bausch & Lomb Americas Inc. | $89.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $2,382.00 | 02/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139385264 | CMS |
| Astellas Pharma US Inc | $115.53 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139325170 | CMS |
| Astellas Pharma US Inc | $151.92 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139433490 | CMS |
| Bausch & Lomb Americas Inc. | $89.17 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140299086 | CMS |
| Ocular Therapeutix, Inc. | $137.43 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148196411 | CMS |
| Ocular Therapeutix, Inc. | $95.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148196413 | CMS |
| Ocular Therapeutix, Inc. | $28.00 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148196415 | CMS |
| Ocular Therapeutix, Inc. | $37.00 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148196417 | CMS |
| Ocular Therapeutix, Inc. | $755.44 | 11/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1148196419 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.